Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-27.59%
↑ 81% vs avg
Percentile
P40
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-142.87%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -27.59% | +89.0% |
| 2024 | -249.88% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2012 | 0.00% | +100.0% |
| 2011 | -579.75% | - |